| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| gsk 3beta inhibitors | 0.47 | 0.8 | 1751 | 10 | 20 |
| gsk | 0.06 | 0.8 | 8711 | 52 | 3 |
| 3beta | 1.55 | 0.4 | 2154 | 58 | 5 |
| inhibitors | 0.07 | 1 | 7593 | 23 | 10 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| gsk 3beta inhibitors | 1.51 | 0.5 | 4759 | 17 |
| gsk 3 beta inhibitor | 1.42 | 1 | 9720 | 54 |
| gsk-3 inhibitor 3 | 1.12 | 0.4 | 8009 | 92 |
| gsk-3 inhibitor | 0.07 | 0.2 | 8008 | 1 |
| gsk-3 inhibitor bio | 1.06 | 0.6 | 3970 | 21 |
| gsk 3b inhibitor clinical trial | 1.27 | 0.1 | 6539 | 33 |
| gsk 3 inhibitor ix | 1.16 | 0.9 | 616 | 63 |
| gsk-3 beta | 1.24 | 0.9 | 8910 | 87 |
| gsk3 inhibitor clinical trial | 1.06 | 0.4 | 7294 | 36 |
| gsk-3-inhibitor-ii | 0.4 | 0.7 | 5129 | 59 |
| gsk3-beta | 1.46 | 1 | 9050 | 48 |
| how to inhibit gsk3b | 1.89 | 0.6 | 4213 | 66 |
| anti-gsk3 beta role in inflammation | 1.31 | 0.2 | 9494 | 74 |
| gsk 3 beta pathway | 1.43 | 0.4 | 5938 | 14 |
| anti-gsk3 beta role in cancer | 0.74 | 0.7 | 1132 | 67 |
| anti-gsk3 beta therapeutic potential | 1.69 | 0.2 | 4928 | 90 |
| anti-gsk3 beta role in diabetes | 0.38 | 0.1 | 1407 | 28 |
